Recombinant	B:C0034861
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	O
cancer	I:C0279530
pain	O
via	O
peroxiredoxin	O
4	I:C0914290
modulation	O
and	O
antioxidation	O
.	O

Recombinant	O
protein	B:C1514562
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	O
cancer	I:C0279530
pain	O
via	O
peroxiredoxin	O
4	I:C0914290
modulation	O
and	O
antioxidation	O
.	O

Recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	B:C0010461
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	O
cancer	I:C0279530
pain	O
via	O
peroxiredoxin	O
4	I:C0914290
modulation	O
and	O
antioxidation	O
.	O

Recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	B:C0279530
cancer	I:C0279530
pain	O
via	O
peroxiredoxin	O
4	I:C0914290
modulation	O
and	O
antioxidation	O
.	O

Recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	O
cancer	I:C0279530
pain	B:C0596240
via	O
peroxiredoxin	O
4	I:C0914290
modulation	O
and	O
antioxidation	O
.	O

Recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	O
cancer	I:C0279530
pain	O
via	O
peroxiredoxin	B:C0914290
4	I:C0914290
modulation	O
and	O
antioxidation	O
.	O

Recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	O
cancer	I:C0279530
pain	O
via	O
peroxiredoxin	O
4	I:C0914290
modulation	B:C1148560
and	O
antioxidation	O
.	O

Recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
superoxide	I:C0010461
dismutase	I:C0010461
alleviates	O
bone	O
cancer	I:C0279530
pain	O
via	O
peroxiredoxin	O
4	I:C0914290
modulation	O
and	O
antioxidation	B:C1148560
.	O

Bone	B:C0279530
cancer	I:C0279530
pain	O
(	O
Bone	O
cancer	I:C0596240
pain	I:C0596240
)	O
is	O
a	O
serious	O
chronic	O
clinical	O
condition	O
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
were	O
considered	O
to	O
be	O
involved	O
in	O
its	O
development	O
and	O
persistency	O
.	O

Bone	O
cancer	I:C0279530
pain	B:C0596240
(	O
Bone	O
cancer	I:C0596240
pain	I:C0596240
)	O
is	O
a	O
serious	O
chronic	O
clinical	O
condition	O
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
were	O
considered	O
to	O
be	O
involved	O
in	O
its	O
development	O
and	O
persistency	O
.	O

Bone	O
cancer	I:C0279530
pain	O
(	O
Bone	B:C0596240
cancer	I:C0596240
pain	I:C0596240
)	O
is	O
a	O
serious	O
chronic	O
clinical	O
condition	O
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
were	O
considered	O
to	O
be	O
involved	O
in	O
its	O
development	O
and	O
persistency	O
.	O

Bone	O
cancer	I:C0279530
pain	O
(	O
Bone	O
cancer	I:C0596240
pain	I:C0596240
)	O
is	O
a	O
serious	O
chronic	O
clinical	O
condition	O
and	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
were	O
considered	O
to	O
be	O
involved	O
in	O
its	O
development	O
and	O
persistency	O
.	O

Bone	O
cancer	I:C0279530
pain	O
(	O
Bone	O
cancer	I:C0596240
pain	I:C0596240
)	O
is	O
a	O
serious	O
chronic	O
clinical	O
condition	O
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
)	O
were	O
considered	O
to	O
be	O
involved	O
in	O
its	O
development	O
and	O
persistency	O
.	O

Normally	O
,	O
superoxide	B:C0038838
dismutase	I:C0038838
(	O
superoxide	O
dismutase	I:C0038838
)	O
converts	O
superoxide	O
anions	I:C0038836
to	O
hydrogen	O
peroxide	I:C0020281
(	O
H2O2	O
)	O
and	O
H2O2	O
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	O
4	I:C0914290
.	O

Normally	O
,	O
superoxide	O
dismutase	I:C0038838
(	O
superoxide	B:C0038838
dismutase	I:C0038838
)	O
converts	O
superoxide	O
anions	I:C0038836
to	O
hydrogen	O
peroxide	I:C0020281
(	O
H2O2	O
)	O
and	O
H2O2	O
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	O
4	I:C0914290
.	O

Normally	O
,	O
superoxide	O
dismutase	I:C0038838
(	O
superoxide	O
dismutase	I:C0038838
)	O
converts	O
superoxide	B:C0038836
anions	I:C0038836
to	O
hydrogen	O
peroxide	I:C0020281
(	O
H2O2	O
)	O
and	O
H2O2	O
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	O
4	I:C0914290
.	O

Normally	O
,	O
superoxide	O
dismutase	I:C0038838
(	O
superoxide	O
dismutase	I:C0038838
)	O
converts	O
superoxide	O
anions	I:C0038836
to	O
hydrogen	B:C0020281
peroxide	I:C0020281
(	O
H2O2	O
)	O
and	O
H2O2	O
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	O
4	I:C0914290
.	O

Normally	O
,	O
superoxide	O
dismutase	I:C0038838
(	O
superoxide	O
dismutase	I:C0038838
)	O
converts	O
superoxide	O
anions	I:C0038836
to	O
hydrogen	O
peroxide	I:C0020281
(	O
H2O2	B:C0020281
)	O
and	O
H2O2	O
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	O
4	I:C0914290
.	O

Normally	O
,	O
superoxide	O
dismutase	I:C0038838
(	O
superoxide	O
dismutase	I:C0038838
)	O
converts	O
superoxide	O
anions	I:C0038836
to	O
hydrogen	O
peroxide	I:C0020281
(	O
H2O2	O
)	O
and	O
H2O2	B:C0020281
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	O
4	I:C0914290
.	O

Normally	O
,	O
superoxide	O
dismutase	I:C0038838
(	O
superoxide	O
dismutase	I:C0038838
)	O
converts	O
superoxide	O
anions	I:C0038836
to	O
hydrogen	O
peroxide	I:C0020281
(	O
H2O2	O
)	O
and	O
H2O2	O
is	O
then	O
naturalized	O
to	O
be	O
water	B:C0043047
by	O
peroxiredoxin	O
4	I:C0914290
.	O

Normally	O
,	O
superoxide	O
dismutase	I:C0038838
(	O
superoxide	O
dismutase	I:C0038838
)	O
converts	O
superoxide	O
anions	I:C0038836
to	O
hydrogen	O
peroxide	I:C0020281
(	O
H2O2	O
)	O
and	O
H2O2	O
is	O
then	O
naturalized	O
to	O
be	O
water	O
by	O
peroxiredoxin	B:C0914290
4	I:C0914290
.	O

We	O
reported	B:C0684224
previously	O
that	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
(	O
protein	O
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	O
excessive	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	O
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

We	O
reported	O
previously	O
that	O
recombinant	B:C0034861
protein	O
transduction	I:C1514562
domain	I:C1514562
(	O
protein	O
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	O
excessive	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	O
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

We	O
reported	O
previously	O
that	O
recombinant	O
protein	B:C1514562
transduction	I:C1514562
domain	I:C1514562
(	O
protein	O
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	O
excessive	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	O
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

We	O
reported	O
previously	O
that	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
(	O
protein	B:C1514562
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	O
excessive	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	O
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

We	O
reported	O
previously	O
that	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
(	O
protein	O
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	B:C0010461
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	O
excessive	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	O
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

We	O
reported	O
previously	O
that	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
(	O
protein	O
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	B:C1148560
excessive	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	O
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

We	O
reported	O
previously	O
that	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
(	O
protein	O
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	O
excessive	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	O
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

We	O
reported	O
previously	O
that	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
(	O
protein	O
transduction	I:C1514562
domain	I:C1514562
)	O
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
effectively	O
scavenged	O
excessive	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
prevented	O
cardiomyocytes	B:C0225828
from	O
hypoxia	O
-	O
reoxygenation	O
damage	O
.	O

However	O
,	O
whether	O
protein	B:C1514562
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
would	O
prevent	O
Bone	O
cancer	I:C0596240
pain	I:C0596240
development	O
is	O
unknown	O
.	O

However	O
,	O
whether	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	B:C0010461
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
would	O
prevent	O
Bone	O
cancer	I:C0596240
pain	I:C0596240
development	O
is	O
unknown	O
.	O

However	O
,	O
whether	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
would	O
prevent	O
Bone	B:C0596240
cancer	I:C0596240
pain	I:C0596240
development	O
is	O
unknown	O
.	O

In	O
the	O
current	O
study	B:C0681814
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	B:C0150312
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	B:C0021102
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	B:C0007097
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	B:C0034721
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	B:C0040184
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	B:C0020429
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	B:C0020281
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	B:C0038838
dismutase	I:C0038838
and	O
peroxiredoxin	O
4	I:C0914290
levels	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
an	O
implanted	O
carcinoma	O
in	O
the	O
rat	O
tibia	O
induced	O
remarkable	O
hyperalgesia	O
,	O
increased	O
H2O2	O
levels	O
and	O
decreased	O
superoxide	O
dismutase	I:C0038838
and	O
peroxiredoxin	B:C0914290
4	I:C0914290
levels	O
.	O

After	O
administration	O
of	O
recombinant	B:C0034861
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
to	O
these	O
tumor	O
-	O
burden	O
rats	O
,	O
their	O
hyperalgesia	O
was	O
significantly	O
attenuated	O
and	O
peroxiredoxin	O
4	I:C0914290
expression	O
was	O
significantly	O
increased	O
.	O

After	O
administration	O
of	O
recombinant	O
protein	B:C1514562
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
to	O
these	O
tumor	O
-	O
burden	O
rats	O
,	O
their	O
hyperalgesia	O
was	O
significantly	O
attenuated	O
and	O
peroxiredoxin	O
4	I:C0914290
expression	O
was	O
significantly	O
increased	O
.	O

After	O
administration	O
of	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	B:C0010461
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
to	O
these	O
tumor	O
-	O
burden	O
rats	O
,	O
their	O
hyperalgesia	O
was	O
significantly	O
attenuated	O
and	O
peroxiredoxin	O
4	I:C0914290
expression	O
was	O
significantly	O
increased	O
.	O

After	O
administration	O
of	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
to	O
these	O
tumor	O
-	O
burden	O
rats	B:C0034721
,	O
their	O
hyperalgesia	O
was	O
significantly	O
attenuated	O
and	O
peroxiredoxin	O
4	I:C0914290
expression	O
was	O
significantly	O
increased	O
.	O

After	O
administration	O
of	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
to	O
these	O
tumor	O
-	O
burden	O
rats	O
,	O
their	O
hyperalgesia	B:C0020429
was	O
significantly	O
attenuated	O
and	O
peroxiredoxin	O
4	I:C0914290
expression	O
was	O
significantly	O
increased	O
.	O

After	O
administration	O
of	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
to	O
these	O
tumor	O
-	O
burden	O
rats	O
,	O
their	O
hyperalgesia	O
was	O
significantly	O
attenuated	O
and	O
peroxiredoxin	B:C0914290
4	I:C0914290
expression	O
was	O
significantly	O
increased	O
.	O

After	O
administration	O
of	O
recombinant	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
to	O
these	O
tumor	O
-	O
burden	O
rats	O
,	O
their	O
hyperalgesia	O
was	O
significantly	O
attenuated	O
and	O
peroxiredoxin	O
4	I:C0914290
expression	B:C1171362
was	O
significantly	O
increased	O
.	O

In	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
N	B:C0080093
-	I:C0080093
methyl	I:C0080093
-	I:C0080093
d	I:C0080093
-	I:C0080093
aspartic	I:C0080093
acid	I:C0080093
(	I:C0080093
NMDA	I:C0080093
)	I:C0080093
receptors	I:C0080093
and	O
a	O
decreased	O
expression	O
of	O
γ-aminobutyric	O
acid	I:C0206518
(	I:C0206518
GABA	I:C0206518
)	I:C0206518
receptors	I:C0206518
in	O
this	O
cancer	O
pain	I:C0596240
were	O
prevented	O
by	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
administration	O
or	O
peroxiredoxin	O
4	I:C0914290
overexpression	O
.	O

In	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
N	O
-	I:C0080093
methyl	I:C0080093
-	I:C0080093
d	I:C0080093
-	I:C0080093
aspartic	I:C0080093
acid	I:C0080093
(	I:C0080093
NMDA	I:C0080093
)	I:C0080093
receptors	I:C0080093
and	O
a	O
decreased	O
expression	O
of	O
γ-aminobutyric	B:C0206518
acid	I:C0206518
(	I:C0206518
GABA	I:C0206518
)	I:C0206518
receptors	I:C0206518
in	O
this	O
cancer	O
pain	I:C0596240
were	O
prevented	O
by	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
administration	O
or	O
peroxiredoxin	O
4	I:C0914290
overexpression	O
.	O

In	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
N	O
-	I:C0080093
methyl	I:C0080093
-	I:C0080093
d	I:C0080093
-	I:C0080093
aspartic	I:C0080093
acid	I:C0080093
(	I:C0080093
NMDA	I:C0080093
)	I:C0080093
receptors	I:C0080093
and	O
a	O
decreased	O
expression	O
of	O
γ-aminobutyric	O
acid	I:C0206518
(	I:C0206518
GABA	I:C0206518
)	I:C0206518
receptors	I:C0206518
in	O
this	O
cancer	B:C0596240
pain	I:C0596240
were	O
prevented	O
by	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
administration	O
or	O
peroxiredoxin	O
4	I:C0914290
overexpression	O
.	O

In	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
N	O
-	I:C0080093
methyl	I:C0080093
-	I:C0080093
d	I:C0080093
-	I:C0080093
aspartic	I:C0080093
acid	I:C0080093
(	I:C0080093
NMDA	I:C0080093
)	I:C0080093
receptors	I:C0080093
and	O
a	O
decreased	O
expression	O
of	O
γ-aminobutyric	O
acid	I:C0206518
(	I:C0206518
GABA	I:C0206518
)	I:C0206518
receptors	I:C0206518
in	O
this	O
cancer	O
pain	I:C0596240
were	O
prevented	O
by	O
protein	B:C1514562
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
administration	O
or	O
peroxiredoxin	O
4	I:C0914290
overexpression	O
.	O

In	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
N	O
-	I:C0080093
methyl	I:C0080093
-	I:C0080093
d	I:C0080093
-	I:C0080093
aspartic	I:C0080093
acid	I:C0080093
(	I:C0080093
NMDA	I:C0080093
)	I:C0080093
receptors	I:C0080093
and	O
a	O
decreased	O
expression	O
of	O
γ-aminobutyric	O
acid	I:C0206518
(	I:C0206518
GABA	I:C0206518
)	I:C0206518
receptors	I:C0206518
in	O
this	O
cancer	O
pain	I:C0596240
were	O
prevented	O
by	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	B:C0010461
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
administration	O
or	O
peroxiredoxin	O
4	I:C0914290
overexpression	O
.	O

In	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
N	O
-	I:C0080093
methyl	I:C0080093
-	I:C0080093
d	I:C0080093
-	I:C0080093
aspartic	I:C0080093
acid	I:C0080093
(	I:C0080093
NMDA	I:C0080093
)	I:C0080093
receptors	I:C0080093
and	O
a	O
decreased	O
expression	O
of	O
γ-aminobutyric	O
acid	I:C0206518
(	I:C0206518
GABA	I:C0206518
)	I:C0206518
receptors	I:C0206518
in	O
this	O
cancer	O
pain	I:C0596240
were	O
prevented	O
by	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
administration	O
or	O
peroxiredoxin	B:C0914290
4	I:C0914290
overexpression	O
.	O

In	O
addition	O
,	O
an	O
increased	O
expression	O
of	O
N	O
-	I:C0080093
methyl	I:C0080093
-	I:C0080093
d	I:C0080093
-	I:C0080093
aspartic	I:C0080093
acid	I:C0080093
(	I:C0080093
NMDA	I:C0080093
)	I:C0080093
receptors	I:C0080093
and	O
a	O
decreased	O
expression	O
of	O
γ-aminobutyric	O
acid	I:C0206518
(	I:C0206518
GABA	I:C0206518
)	I:C0206518
receptors	I:C0206518
in	O
this	O
cancer	O
pain	I:C0596240
were	O
prevented	O
by	O
protein	O
transduction	I:C1514562
domain	I:C1514562
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
administration	O
or	O
peroxiredoxin	O
4	I:C0914290
overexpression	B:C1514559
.	O

Our	O
data	O
suggested	O
that	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	I:C0027627
pain	O
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	O
PTD	I:C0034861
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	O
4	I:C0914290
modulation	O
from	O
oxidative	O
stress	I:C0242606
.	O

Our	O
data	O
suggested	O
that	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	B:C0027627
metastatic	I:C0027627
pain	O
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	O
PTD	I:C0034861
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	O
4	I:C0914290
modulation	O
from	O
oxidative	O
stress	I:C0242606
.	O

Our	O
data	O
suggested	O
that	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	I:C0027627
pain	B:C0596240
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	O
PTD	I:C0034861
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	O
4	I:C0914290
modulation	O
from	O
oxidative	O
stress	I:C0242606
.	O

Our	O
data	O
suggested	O
that	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	I:C0027627
pain	O
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	B:C0034861
PTD	I:C0034861
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	O
4	I:C0914290
modulation	O
from	O
oxidative	O
stress	I:C0242606
.	O

Our	O
data	O
suggested	O
that	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	I:C0027627
pain	O
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	O
PTD	I:C0034861
-	O
Cu	B:C0010461
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	O
4	I:C0914290
modulation	O
from	O
oxidative	O
stress	I:C0242606
.	O

Our	O
data	O
suggested	O
that	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	I:C0027627
pain	O
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	O
PTD	I:C0034861
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	B:C0914290
4	I:C0914290
modulation	O
from	O
oxidative	O
stress	I:C0242606
.	O

Our	O
data	O
suggested	O
that	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	I:C0027627
pain	O
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	O
PTD	I:C0034861
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	O
4	I:C0914290
modulation	B:C1148560
from	O
oxidative	O
stress	I:C0242606
.	O

Our	O
data	O
suggested	O
that	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
at	O
least	O
in	O
part	O
,	O
play	O
a	O
role	O
in	O
cancer	O
metastatic	I:C0027627
pain	O
development	O
and	O
persistency	O
which	O
can	O
be	O
attenuated	O
by	O
the	O
adminstration	O
of	O
recombinant	O
PTD	I:C0034861
-	O
Cu	O
/	I:C0010461
Zn	I:C0010461
SOD	I:C0010461
via	O
the	O
peroxiredoxin	O
4	I:C0914290
modulation	O
from	O
oxidative	B:C0242606
stress	I:C0242606
.	O

